Eli Lilly’s weight-loss pill disappointed in a key trial, but CEO David Ricks and other insiders together bought nearly $3 million worth of stock in the aftermath of the selloff.
Source link
These Eli Lilly executives have been scooping up stock after its big drop
You May Also Like
More From Author
The 4 best things about my first-ever all-inclusive beach resort experience: Almare, a Luxury Collection Resort
